Epitope-tagged Xenopus nucleolin was expressed in Escherichia coli cells and in Xenopus oocytes either as a full-length wild-type protein or as a truncation that lacked the distinctive carboxy glycine/arginine-rich (GAR) domain. Both full-length and truncated versions of nucleolin were tagged at their amino termini with five tandem human c-myc epitopes. Whether produced in E. coli or in Xenopus, epitope-tagged full-length nucleolin bound nucleic acid probes in in vitro filter binding assays. Conversely, the E. coli-expressed GAR truncation failed to bind the nucleic acid probes, whereas the Xenopus-expressed truncation maintained slight binding activity. Indirect immunofluorescence staining showed that myctagged full-length nucleolin properly localized to the dense fibrillar regions within the multiple nucleoli of Xenopus oocyte nuclei. The epitope-tagged GAR truncation also translocated to the oocyte nuclei, but it failed to efficiently localize to the nucleoli. Our results show that the carboxy GAR domain must be present for nucleolin to efficiently bind nucleic acids in vitro and to associate with nucleoli in vivo.
INTRODUCTION
Vertebrate nucleolin is a nucleolar specific phosphoprotein of 90-110 kDa that is believed to quickly associate with nascent preribosomal RNA within the dense fibrillar regions of nucleoli (reviewed by Olson, 1990; Escande et al., 1985; Herrera and Olson, 1986) . Nucleolin is abundant in rapidly dividing somatic cells (Orrick et al., 1973) and amphibian oocytes (CaizerguesFerrer et al., 1989; DiMario and Gall, 1990) where rates of ribosome production are maximal. Herrera and Olson (1986) demonstrated that the majority of nucleolin rapidly associates with newly synthesized pre-ribosomal RNA, and recent studies on the yeast nucleolin-like NSR1 protein showed that 35S preribosomal RNA processing and ribosome biogenesis were impaired when the NSR1 protein was eliminated in a nsrl deletion strain (Kondo et al., 1992a,b) . This combined evidence suggests that nucleolin plays an early role in the processing of preribosomal RNA or in the preassembly of ribosomes (Olson, 1990) .
Nucleolin is a modular protein (Olson, 1990) . Its amino terminal third consists of alternating basic and acidic domains, and the carboxy terminal two-thirds consists of four RNA-binding domains followed by a glycine-and NG,NG dimethylarginine-rich (GAR) do-1993 by The American Society for Cell Biology main Lapeyre et al., 1986) . The amino terminal acidic domains have been implicated in binding histone Hi to decondense rDNA for transcription (Erard et al., 1988 (Erard et al., , 1990 or in binding basic ribosomal proteins to facilitate ribosome assembly (Olson, 1990) . On the other hand, the amino terminal basic domains have been implicated in binding upstream rDNA sequences to regulate rRNA gene expression (Olson et al., 1983) . The four RNA-binding domains are similar to those found in several other RNA-binding proteins such as the heterogeneous nuclear ribonucleoproteins (hnRNPs), poly(A)-binding proteins, and ribonucleoproteins specifically associated with Ul and U2 small nuclear (sn) RNAs (reviewed by . For example, the RNA-binding domain of the Ul snRNP A protein can bind RNA in vitro (Query et al., 1989) , and its crystal structure provides evidence for likely interactions with stem-loop II of Ul snRNA (Nagai et al., 1990) . On the basis of what is already known about these RNA-binding domains in other proteins, we can assume that some or all of nucleolin's four RNA-binding domains are important for observed in vitro RNA and DNA interactions (Olson et al., 1983; Bugler et al., 1987; Sapp et al., 1989) . However, specific in vivo interactions between nucleolin's four RNA-1189 M.A. Heine et al. binding domains and pre-rRNA have yet to be determined.
Just downstream of the fourth RNA-binding domain is the GAR domain that is referred to as the Arg-GlyGly (RGG) box by Dreyfuss et al. (1993) for other RNAbinding proteins. Ghisolfi et al. (1992) have shown that this domain consists of repeated A-turns that confer an overall helical structure on this domain (i.e. a A-spiral), and they have shown that this basic domain binds RNA or DNA independently of the four upstream RNAbinding domains. The GAR domain may nonspecifically bind preribosomal RNA to perhaps unwind secondary structures thereby facilitating more specific interactions between nucleolin and preribosomal RNA (Ghisolfi et al., 1992) . Despite these predictions, the in vivo functions and associations of this GAR domain also remain unknown.
To gain more information about individual domains of nucleolin, specifically the carboxy GAR domain, we have epitope-tagged Xenopus nucleolin at its amino terminus and truncated the protein just before the GAR domain. Here we show that the tagged truncation produced in Escherichia coli no longer binds radiolabeled nucleic acids in vitro and that the tagged truncation produced in Xenopus oocytes fails to efficiently localize to the multiple nucleoli in vivo.
MATERIALS AND METHODS

Recovery of Xenopus Nucleolin cDNAs
The polymerase chain reaction (PCR) was used as described (Frohman et al., 1988) to recover full length Xenopus nucleolin cDNAs. Briefly, Xenopus ovary RNA was purified as described (Epstein et al., 1986) , and poly(A)+ mRNA was further enriched by oligo d(T) chromatography (Kingston, 1993) . To synthesize negative cDNA strands, 1 1sg of poly(A)+ RNA was reverse transcribed using a cDNA Synthesis System Plus kit (Amersham, Arlington Heights, IL) according to the manufacturer's recommended protocol. A Xenopus nucleolin-specific oligonucleotide was used in the PCR as the 5' primer for the synthesis of positive nucleolin cDNA strands. This primer was homologous to nucleotides of an incomplete Xenopus nucleolin cDNA except that nucleotides 34 (G) and 35 (C) were changed to C and T, respectively to provide a HindIII site for cloning purposes. The 3' oligonucleotide primer contained poly (dT) at its 5' end and XhoI, SalI, and Clal restriction sites at its 3' end for subsequent cloning. The PCR cycles were carried out essentially as described (Frohman et al., 1988 ) using a Perkin-Elmer-Cetus DNA Thermal Cycler (Norwalk, CT) and TaqI polymerase. A predicted PCR product of -2000 base pairs (bp) was gel purified, cut with HindIII and XhoI to generate sticky ends, and ligated into a pBluescript vector (Stratagene, La Jolla, CA) at the appropriate polylinker sites. The PCR product was determined to encode nucleolin by sequence analysis using a dideoxy Sequenase kit (United States Biochemicals, Cleveland, OH).
A 645-bp HindIII/EcoRI fragment from the 5' end of the PCR product was used to screen a Xenopus ovary cDNA lambda-ZAP library (Stratagene). Several positive cDNA clones were selected on the basis of size and three previously identified internal EcoRI sites (CaizerguesFerrer et al., 1989) . Single-and double-stranded sequencing techniques were used to further characterize several of these cDNAs. Two cDNAs, XlC23-92 and XlC23-56, were completely sequenced as described.
Their sequences overlap and a full-length nucleolin cDNA was constructed by ligating the two cDNAs at a common XbaI site shown in Figure 1 . The EMBL accession number for this full length nucleolin cDNA is X63091.
Computer Sequence Analysis
Analyses of the Xenopus nucleolin cDNA sequence and the deduced protein sequence were performed using the University of Wisconsin Genetics Computer Group Sequence Analysis Software Package, Version 7.1 (Devereux et al., 1984) .
cDNA Subcloning and Mutagenesis A 13-amino acid segment of the human c-myc protein has been used successfully as an epitope to tag cellular proteins (Monro and Pelham, 1986) . Six tandem repeats of the DNA encoding the myc epitope were subsequently constructed and cloned downstream of the T3 promoter of pBluescript by Roth et al. (1991) . For our studies the 5' end of the nucleolin coding sequence was ligated to the 3' end of the fifth tandem myc DNA repeat by using common NcoI sites, one shortly downstream of the fifth myc tag and the other at the predicted ATG translation start codon of the nucleolin cDNA. Ligation between the myc and nucleolin cDNA sequences placed 5 tandem myc repeats upstream and in frame with the nucleolin ATG start codon. The fifth myc repeat unit was followed by an additional eight nonnucleolin amino acids (MESLGDLT) and then the initial methionine of nucleolin. Although the nucleolin ATG start codon was left intact, each myc DNA repeat begins with its own ATG translation start codon. The ,B-gal promoter of pBluescript was upstream of the T3 promoter, and it permitted bacterial expression of the myc-tagged fusion protein. The resulting myc-nucleolin construct is referred to as pmyc-XIC23.
The X1C23-56 cDNA that was used to construct pmyc-XIC23 contains the 3' untranslated region, but it has no poly(A) sequence. To ensure stability of oocyte-injected mRNA, the 3' untranslated region of Xenopus N038 cDNA with a poly(A) tail of 59 residues was used to replace most of the nucleolin 3' untranslated region of pmyc-XIC23.
Specifically, the 3' untranslated region of the N038 cDNA was excised by cutting at an EcoRV site that had been engineered within the 3' untranslated region (construct C11 of Peculis and Gall, 1992) and at a downstream SacI polylinker site. The resulting 400-bp N038 fragment was ligated to pmyc-XlC23 that had been first cut with SpeI; its ends made flush with the Klenow polymerase fragment and then cut again at a downstream SacI polylinker site. The resulting plasmid is called pmyc-XIC23-NO38. E. coli and Xenopus oocyte translation products, derived from pmyc-XlC23-NO38, are depicted in Figure 1 , A and B, respectively. The carboxy terminus of nucleolin was truncated upstream of the GAR domain by cutting pmyc-XIC23-NO38 at the unique XbaI site (Figure 1 ), filling in the overhangs with the Klenow polymerase fragment and then religating the plasmid. This procedure introduced four extra base pairs that shifted the reading frame such that the original nucleolin sequence of -L573DFAKPKG580-(where G580 is 4 residues upstream of the GAR domain) was changed to -L573ARLCKT*. The (*) denotes a newly created stop codon that is positioned less than four codons upstream of the GAR-encoding DNA sequence. Sequence analysis verified the predicted mutagenesis, and the resulting plasmid is referred to as pmyc-XlC236GAR. E. coli and Xenopus oocyte translation products, derived from pmyc-XIC235GAR, are depicted in Figure   1 , C and D, respectively.
Bacterial Expression
The protease deficient E. coli strain, BL21 (Sturdier et al., 1990) , and the recombination deficient E. coli strain, XL1-Blue, were transformed with cesium chloride-banded pmyc-XIC23-NO38 or pmyc-XIC236GAR. The BL21 was cotransformed with pUBS520 (from Dr. R. Mattes, Institut fur Industrielle Genetik, Universitat Stuttgart, Stuttgart). pUBS 520 is a derivative of pACYC 177 that was modified to contain the E. coli laclq gene that encodes the lac repressor to prevent weak constitutive expression from lactose inducible promoters.
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Xenopus Nucleolin Localization pUBS520 also carries the argU (formerly called dnaY) gene of E. coli (Brinkman et al., 1989) for high level fusion protein expression. Fusion protein expression was induced with isopropyl ,B-D-thiogalactopyranoside (IPTG) once cultures had reached an OD600 of 0.5 at 37°C. Cells were allowed to express fusion protein for 3 h at 37°C with vigorous shaking after which the cells were pelleted, resuspended in 0.5 ml of sodium dodecyl sulfate (SDS)-sample buffer (Laemmli, 1970) , and lysed by sonication. Samples were boiled for 5 min and then clarified by centrifugation. E. coli-expressed translation products derived from pmyc-XlC23-NO38 or pmyc-XIC236GAR are depicted in Figure 1 , A and C, respectively.
Oocyte Injections
An 37°C for 15 min. The mixture was then adjusted to 100 Ml with the addition of distilled water, adjusted to a final concentration of 300 mM sodium acetate, and then extracted with phenol/chloroform. RNA transcripts were precipitated with ethanol, pelleted by centrifugation, washed with 70% ethanol, vacuum dried, and then dissolved in distilled water to -1 mg/ml for oocyte injection. RNA integrity was assayed by Northern blot analysis as described by Epstein et al. (1986) . Xenopus-expressed translation products that were derived from pmyc-XIC23-NO38 or pmyc-XIC236GAR are depicted in Figure 1 , B and D, respectively. Female Xenopus frogs were purchased from Xenopus I (Ann Arbor, MI). Individual oocytes were removed from ovary and incubated for 1 h in OR2 medium at 18°C before mRNA injection. OR2 medium is 82.5 mM NaCl, 2.5 mM KCl, 1.0 mM CaCl2, 1.0 mM MgCl2, 1.0 mM Na2HPO4, and 5.0 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Wallace et al., 1973) . Messenger RNA encoding myctagged nucleolin fusion protein was injected into stages 5 and 6 oocytes. After injection the oocytes were incubated in OR2 medium at 18°C for 18-24 h. The nuclear contents consisting of lampbrush chromosomes, multiple nucleoli, and RNP particles were prepared for immunofluorescence microscopy by the procedures of Gall et al. (1991) . Specifically, oocyte nuclei were individually hand isolated in freshly prepared 5:1 isolation medium (83 mM KCl, 17 mM NaCl, 1.0 mM Mg+2, and 10 mM tris(hydroxymethyl)aminomethane [Tris] pH 7.2). A nucleus was cleaned of cytoplasm by drawing it up and down in a pulled Pasteur pipette after which the nuclear envelope was removed with No. 5 Dumont (Regine, Switzerland) forceps. The nuclear contents remain as a gelatinous plug in this 5:1 isolation buffer. The plug was then transferred by pipette to "quarter strength" dispersal medium (20.75 mM KCl, 4.25 mM NaCl, 2.5 mM Tris pH 7.2, with 0.1% paraformaldehyde, 0.5-1.0 mM MgCl2, and 5-10 AM CaCl2) for '30 sec and then to a droplet of fresh dispersal medium placed into a well that was constructed on a protein-coated microscope slide (for details see Gall et al., 1991) . The Mg+2 and Ca+2 concentrations in this spreading medium were adjusted within the indicated ranges to ensure consistent dispersal from one batch of oocytes to the next. For example, decreasing the Mg+2 concentration and increasing the Ca+2 concentration facilitates dispersal, whereas increasing the Mg+2 concentration and decreasing the Ca+2 concentration impedes dispersal (Gall et al., 1991) . Without proper dispersal, the nuclear contents remain as a condensed gelatinous plug, and we have noted that the nucleoli do not stain well with various anti-nucleolin antibodies (see below) under these conditions. Once in dispersal medium, the nuclear contents were allowed to settle onto the slides and spread. To permanently affix the nuclear contents to the glass, the slides were centrifuged at 4500 rpm for 1 h in a Sorvall HS4 rotor (Newton, CT) that was equipped with specially built slide carriers (see Gall et al., 1991 ). The nuclear preparations were then fixed with 2% paraformaldehyde in phosphate-buffered saline (PBS) that contained 1 mM MgCl2. The final preparations were blocked with 10% horse serum in PBS and then probed with various antibodies.
Total Nuclear Proteins, Gel Electrophoresis, and Southwestern Analysis Nuclear proteins were prepared from hand isolated oocyte nuclei that were stripped of clinging cytoplasm by pipetting up and down (Roth and Gall, 1987) . SDS-polyacrylamide gel electrophoresis was according to Laemmli (1970) . Two-dimensional (2-D) isoelectric focusing of oocyte nuclear proteins was as described (DiMario and Gall, 1990) . Western blots were probed with labeled, heat denatured DNA ("Southwesterns") as previously described (DiMario et al., 1989) .
Nucleolin Purification and Antiserum Production
Nucleolin was purified from S100 extracts of Xenopus kidney cells (X1K2) by anion exchange chromatography and poly[G]-agarose chromatography. The extract was prepared according to the procedures of Reeder (1986, 1990) . In the purification of nucleolin, an aliquot (17 ml) of cell extract was applied to DEAE-Sepharose (DCL-6B-100, Sigma, St. Louis, MO) packed in a 20 X 1.5 cm I.D. BioRad Econo column Richmond, CA. The beads had been previously equilibrated in column buffer (20 mM Tris * HCl pH 6.2, 6 M urea, 1 mM dithiothreitol, and 1 mM EDTA). A linear gradient of NaCl (0.0-0.75 M, 350 ml total volume) passed through the column at 4°C. Each fraction (5.6 ml) was monitored by A223 and A280 to establish a column elution profile. Fraction aliquots (0.25 ml) were precipitated with 1 ml of acetone, and the pellets were resuspended in 50 Ml of SDS sample buffer (Laemmli, 1970) . Fractions were resolved on a 10% polyacrylamide SDS gel, transferred to nitrocellulose, and probed with monoclonal antibody (mAb) G1C7 and secondary reagents from the Vectastain detection kit (Vector Laboratories, Burlingame, CA). Nucleolin typically eluted from the cellulose diethylaminoethyl-cellulose (DEAE) column at -0.35 M NaCl. Those fractions enriched for nucleolin were dialyzed overnight in poly [G] column buffer (50 mM Tris base pH 7.9, 5mM MgCl2, and 1 mM EDTA) at 4°C. Dialyzed fractions were loaded onto a 5 ml poly[G]-agarose resin (P1908, Sigma) that had been packed in a 9 X 1.5 cm I.D. BioRad Econo column and equilibrated with poly[G] column buffer. A linear gradient of KCl (0.0-1.0 M, total volume of 140 ml) was passed through the column at 4°C. The flow rate was slowed to 0.35 ml/min using a peristaltic pump. Fractions of 3 ml were collected and the A223 and A280 were again read for each fraction to obtain a column elution profile. Aliquots (0.5 ml) of the fractions were precipitated with 2 ml of 100% acetone and pelleted. Pellets were resuspended in 50 MlI of SDS sample buffer, and individual fractions were resolved on a 10% polyacrylamide SDS gel. Polyacrylamide gels were silver stained to determine which fractions contained only nucleolin. Nucleolin typically eluted from the poly[G]-agarose column at -0.75 M KCl.
Purified nucleolin was next transferred to sterile PBS and condensed using an Amicon condenser (Dancers, MA) and Millipore spin columns (Bedford, MA) to a final volume of 0.2 ml. The protein sample was then emulsified with 0.2 ml of Freund's complete adjuvant (F-4258, Sigma) and injected subcutaneously into a female New Zealand white rabbit. The rabbit was boosted twice; each boost used Freund's incomplete adjuvant (F-5506, Sigma), and each boost was administered 3 weeks after the previous injection. The resulting polyclonal serum (R2D2) was characterized for anti-nucleolin specificity by probing Western blots that contained a complex mixture of cellular proteins ( Figure 5B). 
Other Antibodies
Mouse mAb 9E10 was originally developed by Evan et al. (1985) ; it labels the myc repeat peptide used to tag nucleolin. Mouse Gall, 1990) . Their migrations are anomalous because of the overall acidic charge of Xenopus nucleolin (calculated pl = 4.65; observed pl = 5.0-5.2) (DiMario and Gall, 1990) . Other proteins that show anomalous migrations on SDS-gels include nucleoplasmin (Dingwall et al., 1987) , the RNA-binding hnRNP proteins C1/C2 (Swanson et al., 1987) , and the RNAbinding protein of the fragile X gene, FMR1 (Siomi et al., 1993) . All have acidic stretches like nucleolin. The amino terminal third of Xenopus nucleolin is a modular composition of alternating basic and acidic domains (Figure 1 ), as in chicken (Maridor and Nigg, 1990) and Chinese hamster ovary (CHO) nucleolin . Although shorter in overall length, the amino terminal region of Xenopus nucleolin contains five acidic domains and six basic domains, rather than four acidic and five basic domains as found in chicken and CHO nucleolin. As in other vertebrate versions of nucleolin, the carboxy two-thirds of Xenopus nucleolin consists of four RNA-binding domains, a GAR domain, and finally a short tail of seven amino acids ( Figure 1A ).
Wild-Type Xenopus Nucleolin Expression in E. coli
A 13-amino acid fragment of human c-myc (MEQKLI-SEEDLNE) has been used successfully to epitope tag several different proteins and then to localize these proteins within cell compartments Pelham, 1986, 1987; Pelham et al., 1988) . Six DNA repeats encoding the myc tag were cloned into pBluescript downstream of the f3-galactosidase and T3 promoters by Roth et al. (1991) . Induction of the ,B-galactosidase promoter in E. coli with IPTG should produce a fusion protein of 751 amino acids that consists of a small lacZ peptide, five myc-tags, the eight amino acid linker, and then nucleolin. Figure 1A depicts this entire E. coli fusion protein.
Endogenous nucleolin from vertebrate cells can be observed simply by probing western blots with radiolabeled, single-stranded DNA (DiMario and Gall, 1990) . We have used this filter binding assay in the studies reported here not to define in vivo functions but rather to monitor nucleolin's production in E. coli and to test the potential of wild-type nucleolin and various mutations of nucleolin to bind DNA under a set of defined in vitro conditions. Figure 2A shows a Western blot that was probed with radiolabeled single-stranded DNA to detect E. coli-produced nucleolin fusion proteins. Lanes 1 and 2 contain proteins from the protease deficient BL21 strain of E. coli (Sturdier et al., 1990 ) that was transformed with pmyc-XlC23. A novel DNA-binding protein of 120 kDa was observed in extracts of IPTGinduced cells (Figure 2A , lane 1), but no DNA-binding protein of this weight was found in extracts of the same cells that were not induced ( Figure 2A, lane 2) . A nonprotease deficient E. coli strain, XL1-Blue, was also transformed with pmyc-XlC23. The 120-kDa, DNA-binding protein was again observed in this strain only after IPTG induction (Figure 2A, lanes 3 and 4) . As a negative control, E. coli cells were transformed with a Bluescript-based plasmid containing a newt cDNA insert that when induced with IPTG, produces a fusion protein that is detectable with mAb 3A10, an anti-histone Hi antibody (DiMario and Gall, 1990 ). This plasmid, referred to simply as p3A10-positive, failed to produce a novel DNA-binding protein either with or without IPTG induction (Figure 2A , lanes 5 and 6, respectively). A prominent single-stranded DNA-binding protein of 61 kDa was observed in all E. coli lysates whether the lysates were prepared from induced or noninduced cells, and whether or not they contained plasmids encoding nucleolin ( Figure 4A, lanes 1-6) . Because of its presence in all E. coli lysates, we were confident that the 61 kDa was not a proteolytic fragment of the 120 kDa DNA-binding protein (see below).
The apparent molecular weight of the 120 kDa DNAbinding protein and its presence only in lysates of induced cells strongly indicated that it was the nucleolin fusion protein. To test this we used mAb 9E10 that reacts well with the myc epitope (Evan et al., 1985) . Figure 2B shows the same blot that was used in Figure 2A , but after it was reprobed with mAb 9E10. The primary 9E10 antibody was detected by immunochemical staining. The prominent antigen of Figure 2B , lane 1' co-migrated with the 120 kDa DNA-binding protein observed in Figure 2A, Figure 2A . Because we were able to resolve the 61-kDa DNA-binding from the 64-kDa antigen on the gradient polyacrylamide gels in Figure 2 , we were confident that the 64-kDa antigen was not related to the smaller E. coli-specific nucleic acid-binding protein.
1193 Vol. 4, November 1993 In addition to the intact 120-kDa and truncated 64-kDa antigens, several other proteolytic fragments of 108 kDa were observed in lysates prepared from induced XL1 -Blue cells that contained pmyc-XlC23 ( Figure  2B , lane 33. The myc tags were still present at their amino termini. Therefore, proteolysis had to occur at the carboxy end of the proteins. Simply on the basis of apparent molecular weights, the difference in size between the intact 120-kDa fusion protein and these 108-kDa fragments suggested that -9% of the intact fusion protein was missing. Although the GAR domain and the very carboxy tail actually constitute 9% of the overall linear length of the E. coli-expressed fusion protein (68 out of 751 total amino acid residues), these crude estimates merely suggested that the GAR domain was missing from the 108-kDa antigens.
To test if the GAR domain is required for in vitro DNA-binding activity, we truncated the fusion protein by engineering a stop codon in the pmyc-XIC23-NO38 expression plasmid at an unique Xba I site (compare Figure 1 , A and C). The resulting plasmid, pmycXlC235GAR, was expressed in E. coli. Labeling with mAb 9E10 showed that the tagged GAR truncation was indeed present within the cell lysate ( Figure 2D , lane 2'). However, it failed to bind radiolabeled DNA ( Figure  2C , lane 2). The truncation's apparent molecular weight of 107 kDa was in good agreement with the predicted loss of -9% of the intact fusion protein of 120 kDa (Figure 2, C and D, lanes 1 and 1' ). Failure to bind the probe under these conditions suggested that the GAR domain must either bind nucleic acids directly as suggested by Ghisolfi et al. (1992) or regulate the conformational state of other nucleic acid binding domains within nucleolin by intramolecular peptide-peptide interactions.
Xenopus Oocyte Expression
The in vitro binding results with fusion proteins produced in E. coli only suggested potential nucleic acid interactions that may be important for nucleolin association within the nucleoli for preribosomal RNA processing or perhaps ribosome assembly and transport. To approach possible in vivo associations and functions, we produced epitope-tagged versions of nucleolin that were either full length ( Figure 1B) or deleted for the carboxy GAR domain ( Figure 1D ) in Xenopus oocytes.
These tagged proteins were produced by injecting mRNAs that were in vitro synthesized from pmyc-XIC23-NO38 or pmyc-XlC236GAR, respectively. Both mRNAs were synthesized using the T3 promoter just upstream of the myc-tags. Therefore, unlike translation initiation in E. coli, translation initiation in Xenopus oocytes should have occurred at the initial AUG codon of the first myc tag. As a result, the lacZ portion of the fusion should be absent, and the Xenopus-produced fusion proteins should be slightly smaller than their counterparts expressed in E. coli (Figure 1, B and D) .
Oocyte-expressed nucleolin fusion proteins were tested first for their ability to bind single-stranded DNA. Hand isolated nuclei from noninjected oocytes contain two prominent DNA-binding proteins of 90 and 95 kDa ( Figure 3A, lane 1) . These are the endogenous versions of Xenopus nucleolin that we previously characterized by this filter binding assay (DiMario and Gall, 1990) . In addition to the two endogenous nucleolin proteins, hand-isolated nuclei from oocytes that were injected with mRNA encoding myc-tagged, full-length nucleolin ( Figure 1B) , contained a novel DNA-binding protein of 102 kDa. The size of the novel protein suggested that the predicted 8.7 kDa myc tag was fused to a protein of 93.8 kDa, which is in close agreement with the observed apparent weights of either the 90 or the 95 kDa endogenous nucleolin protein. All other detected binding proteins from the nuclei of injected oocytes were common to nuclei of noninjected oocytes (compare Figure  3A , lanes 1 and 2).
The western blot used in Figure 3A was reprobed with mAb 9E10 ( Figure 3B ). Nuclei from noninjected oocytes contained no detectable antigen ( Figure 3B Molecular Biology of the Cell nuclear extracts from oocytes that had been injected with the mRNA ( Figure 3B , lane 2'). We concluded that the 102-kDa antigen was the epitope-tagged nucleolin fusion protein because it was found only in nuclei that were isolated from injected oocytes, and because it had an identical apparent molecular weight when compared to the novel DNA-binding protein in the Southwestern assay.
As in the E. coli extracts, a myc-tagged proteolytic fragment was found in the nuclear extracts from mRNAinjected oocytes ( Figure 3B, lane 2' ). Its apparent molecular weight of 62 kDa indicated that it contained, in addition to the myc-tags, at least the amino terminal one-third and perhaps even the first two RNA-binding domains within the carboxy terminal two-thirds of nucleolin. The similarity in size between the E. coli-expressed, myc-tagged, 64-kDa proteolytic fragment and the myc-tagged 62-kDa Xenopus fragment intrigued us. If we assume that these fragments were in fact generated from intact nucleolin by proteolysis, and if we allow for the presence of the short lacZ peptide on the 64-kDa E. coli fragment versus the 62-kDa oocyte fragment, then nucleolin expressed in either E. coli or Xenopus oocytes may have been cleaved at sites that lie in close proximity. Reports have suggested that proteolysis is a programmed event in the maturation of the 110-kDa CHO nucleolin (Bugler et al., 1982; Bourdon et al., 1983a) with the size of CHO proteolytic fragments ranging from 45-95 kDa (Bourdon et al., 1983b In addition to the myc-tagged full-length protein, we also tested the oocyte-expressed GAR truncation for its ability to bind radiolabeled DNA by Southwestern assay. However, a novel DNA-binding protein was not evident ( Figure 3C, lane 1) . Staining the blot with mAb 9E10 showed that the tagged GAR truncation was in fact present within the nuclear extract but that it comigrated with the 95-kDa endogenous nucleolin protein ( Figure 3D, lane 1') . In characterizing the oocyte-expressed GAR truncation, we concomitantly expressed full-length myc-tagged nucleolin in separate oocytes as a positive control for DNA binding, as a control for antibody (mAb 9E10) staining, and as a demonstration of a shift in molecular weight between the GAR truncation and the intact nucleolin fusion protein (Figure 3 , C and D, lanes 2, 2). Unfortunately, the comigration of the GAR truncation with the 95-kDa endogenous protein negated our attempts to test the in vitro binding capabilities of the GAR truncation by this one-dimensional Southwestern assay.
Because dimethylation does not change the positive charge of the arginine side group (Ghisolfi et al., 1992) , we reasoned that the GAR truncation should be more acidic than the endogenous proteins because of the lack of the arginine-rich domain. Therefore, a 2-D Southwestern blot was employed to separate the endogenous forms of nucleolin from the myc-tagged GAR truncation. The 2-D protein blot was probed with labeled DNA ( Figure 4A ) and then with mAb 9E10 (Figure 4B ). Several isoelectric variants of the 90-and 95-kDa endogenous nucleolin proteins were evident by DNA-binding. These variants exist probably because of various degrees of nucleolin phosphorylation. The most acidic DNAbinding protein of 95 kDa ( Figure 4A ) colocalized with an antigen that stained well with mAb 9E10 ( Figure  4B ). This colocalization indicated that the oocyte-expressed myc-tagged GAR truncation maintained some nucleic acid binding capabilities.
Evidence from E. coli expression experiments showed that the smallest myc-tagged (i.e., mAb 9E10-positive) proteolytic fragment of -10 kDa could be labeled by mAb G1C7. This indicated that the G1C7 epitope resided within the amino terminal region of nucleolin. With this knowledge, we used mAb G1C7 to roughly estimate the amount of the GAR truncation present within the oocyte nuclear extract relative to endogenous nucleolin proteins by comparing a combination of mAb G1C7 staining intensities and autoradiographic spot sizes on the 2-D blots. For this comparison we used another aliquot of the same protein sample used in Figure 4, A and B . On the basis of G1C7 staining ( Figure  4C ), we conservatively estimated that the amount of GAR truncation within the lysate was comparable to one of the minor isoelectric variants (see arrows in Figure  4C ). But when the DNA-binding signals of the GAR truncation and the same isoelectric variant were compared (arrows in Figure 4A ), it appeared that the GAR truncation failed to bind DNA as efficiently as did the minor isoelectric variant.
Finally, mAb G1C7 labels higher molecular weight proteins that have less acidic isoelectric points (arrowhead in Figure 4C ). These proteins have not been identified, and this cross-reactivity precludes us from using mAb G1C7 in fluorescence localization experiments described below.
Characterization of Anti-Nucleolin Serum R2D2 Before we could pursue the localization of myc-tagged nucleolin in Xenopus oocyte nuclei, it was first necessary to establish the localization of endogenous nucleolin. Because mAb G1C7 labeled proteins other than nucleolin ( Figure 4C ), a highly specific polyclonal serum directed against Xenopus nucleolin was prepared. The two versions of nucleolin were purified from S100 cell extracts ( Figure 5A, lane 1 .~~~~~~~~~~~~~l abeled only the two nucleolin proteins versus a large complex mixture of cellular proteins ( Figure 5B , lanes 1-3).
kDa Endogenous Nucleolin Localizations
Previous reports showed that nucleolin primarily associates with the dense fibrillar regions of nucleoli (Noaillac-Depeyre et al. 1989; Biggiogera et al. 1991) .
Fibrillarin is a nucleolar-specific protein that is known I:...
to reside within the dense fibrillar regions (Ochs et al., wa 90 1985) . Therefore, to identify the dense fibrillar regions 90 of the multiple nucleoli, we prepared the contents of nuclei from noninjected oocytes according to the procedures of Gall et al. (1991) , and then probed these preparations with mouse anti-fibrillarin antibody, mAb 72B9, followed by fluorescein-coupled goat anti-mouse.
9E10
Figure 6A is a phase contrast micrograph showing several Xenopus oocyte nucleoli that were prepared from kDa the same nucleus but ranged in size from 5 to 10 ,um. mAb 72B9 staining was restricted to internal regions (dense fibrillar regions) of the nucleoli, whereas the peripheral regions (the granular regions) were not stained. No other nuclear structure was stained by mAb 72B9 ( Figure 6B ). We next counterstained these same nucleoli -95
with rabbit serum R2D2 and rhodamine-coupled mouse -90
anti-rabbit ( Figure 6C ). R2D2 intensely stained the same regions that mAb 72B9 stained. The colocalization of mAb 72B9 and our rabbit anti-nucleolin clearly established that fibrillarin and nucleolin colocalized to the dense fibrillar regions of the multiple nucleoli. Besides the dense fibrillar regions, however, R2D2 also lightly 1 C7
stained the surrounding granular regions of the nucleoli; the presence of nucleolin within nucleolar granular regions has been previously described (Noaillac-Depeyre kDa et al. 1989; Biggiogera et al. 1991) . The staining patterns _ -18 0 in Figure 6 , B and C indicated that the granular regions of these Xenopus multiple nucleoli were very narrow bands surrounding the dense fibrillar regions and that the granular regions constituted a small percentage of 95 the overall nucleolar mass.
- 90 We often observed understained spots within the very center of the nucleoli with either mAb 72B9 ( Figure 6B ) or R2D2 ( Figure 6C ). We interpreted these regions as the fibrillar centers that were noted to be deficient in tethe oocyte-expressed fibrillarin (Ochs et al., 1985) nucleus rather than localized solely to the nucleoli (Rankin and DiMario, unpublished data). Figure 1B . Localization of myc-tagged full-length nucleolin to the nucleoli by staining with mAb 9E10 and fluoresceincoupled goat anti-mouse is shown in Figure 7B . In addition to the nucleoli, surrounding RNP particles were stained, which indicated that the myc-tagged nucleolin associated with these extranucleolar RNP particles, as Figure 6C indicated. We assume that part of this extranucleolar staining was because of an overexpression of the fusion protein and that the majority of tagged nucleolin was actually not associated with the multiple nucleoli. The immunoblots of Figure 3 showed that the majority of myc-tagged nucleolin was intact. This suggested that the immunofluorescence staining in Figure   7B also localized mostly intact nucleolin fusion protein.
Besides labeling endogenous nucleolin, mouse mAb G1C7 ( Figure 4C ) and rabbit serum R2D2 label myctagged versions of nucleolin on Western blots. Therefore, we cannot localize only endogenous nucleolin versus myc-tagged nucleolin by using either antibody. However, if myc-tagged nucleolin colocalized with endogenous versions of nucleolin, the staining patterns with mouse mAb 9E10 and rabbit serum R2D2 should be similar. To test this we counterstained the nucleoli of Figure 7A with R2D2 and rhodamine-coupled goat anti-rabbit IgG. Figure 7C shows similar staining patterns as in Figure 7B . The colocalization of myc-tagged full-length nucleolin with endogenous nucleolin indicated that the myc tags did not interfere with nuclear translocation nor with nucleolar association.
In most cases, staining with the anti-nucleolin serum was very bright, and substructure was not readily discernable. However, some of the larger nucleoli that were separated away from the RNP material showed detailed substructure when stained with 9E10 or R2D2. The top left insets in Figure 7 , A-C show such nucleoli from a similarly injected oocyte. Both mAb 9E10 and R2D2 stained the phase-dense regions of these nucleoli. Based upon the localizations of Figure 7 , A-C, we concluded that the myc-tagged, full-length nucleolin colocalized with endogenous nucleolin primarily within the dense fibrillar regions of the nucleoli that were defined by the double-labeling experiment of Figure 6 .
In the above double-labeling experiments, we first probed the nuclear preparations with mAb 9E10 and fluorescein-coupled goat anti-mouse antibody. We recorded the fluorescein results on film before reprobing with R2D2 and rhodamine-coupled mouse anti-rabbit. The reason for this laborious approach was to eliminate the possibility that fluorescein-coupled goat anti-mouse antibody might cross-react with R2D2 or the rhodamine-coupled mouse anti-rabbit. To control for the possibility that the rhodamine-coupled mouse anti-rabbit IgG cross-reacted with mAb 9E10 or the fluoresceincoupled goat anti-mouse used to detect mAb 9E10, we probed the nuclear contents from a similarly injected oocyte ( Figure 7A , top right inset) with mAb 9E10 and fluorescein-coupled goat anti-mouse. We left out rabbit serum R2D2 but reprobed with rhodamine-coupled mouse anti-rabbit. A strong signal was again detected in the fluorescein channel that localized myc-tagged nucleolin to the nucleoli ( Figure 7B , top right inset), but no signal was detected in the rhodamine channel ( Figure  7C , top right inset). This control was necessary to show that cross-reactivity by rhodamine-coupled mouse antirabbit with mAb 9E10 or its fluorescein-coupled secondary antibody did not account for the signals in Figure 7C . Vol. 4, November 1993 1197 (Figure 4 ). Its reduced in vitro nucleic acid binding capabilities next prompted us to determine if the GAR truncation could properly associate with nucleoli in vivo.
We knew from the results of Figure 3D and Figure 4 that the myc-tagged GAR truncation successfully translocated from the site of synthesis in the cytoplasm into the nuclei. To determine if the GAR-truncation associated with the multiple nucleoli, oocytes were again injected with mRNA that was in vitro transcribed from pmyc-XIC236GAR. The oocyte translation product is depicted in Figure 1D . When probed with mAb 9E10, the multiple nucleoli were reproducibly understained ( Figure 7E ) as compared to nucleoli from oocytes that were injected with mRNA encoding myc-tagged fulllength nucleolin (e.g., see Figure 7 , B and E).
As with the localization of myc-tagged full-length nucleolin, the tagged GAR truncation associated with extranucleolar RNP material. On the basis of similar RNP staining intensities in Figure 7 , B and E, the amount of tagged GAR truncation within the extranucleolar RNP material appeared comparable to the amount of tagged full-length nucleolin within this material. In the absence of any significant nucleolar staining in Figure  7E , this RNP staining served as an internal positive control for the presence of the GAR truncation within the nuclei, as Figure 3D indicated.
Anti-nucleolin rabbit serum R2D2 was again used to localize both the endogenous nucleolin and the GARtruncation. R2D2 stained the nucleoli that demonstrated the presence of only endogenous nucleolin ( Figure 7F ) and, as expected, R2D2 stained the extranucleolar RNP material. The differential nucleolar staining with mAb 9E10 versus R2D2 (e.g., compare Figures 7, E and F) clearly demonstrated that the myc-tagged GAR truncation failed to efficiently localize to the multiple nucleoli.
Finally, to control for the possibility that the fluorescein-coupled goat anti-mouse cross-reacted with the RNP material and for autofluorescence in the fluorescein channel, a similar preparation from an injected oocyte ( Figure 7D inset) was probed with only this secondary antibody and not mAb 9E10. No signal was detected ( Figure 7E inset).
DISCUSSION
We have chosen the Xenopus oocyte to gain more information about the in vivo associations of nucleolin. Ribosomal DNA amplifies in the pachytene stage of oogenesis by rolling circle replication (Brown and Dawid, 1968; Gall, 1968) . As much as 30 pg of rDNA per oocyte is then separated into multiple nucleoli; the nucleus of a typical diplotene Xenopus oocyte contains 1000 extra-chromosomal nucleoli. Transcription of this rDNA produces large quantities of nascent 45S ribosomal RNA that is quickly processed to yield mature 18S, 5.8S, and 28S ribosomal RNA (reviewed by Gerbi et al., 1990) . The production of ribosomes in the diplotene oocyte is tremendous; some 300 000 ribosomes are assembled per second within the oocyte (Scheer, 1973) , whereas 10-100 ribosomes are assembled per second in a typical nondividing somatic cell (Hadjiolov, 1985) . Besides the high rates of ribosome production, other advantages in using Xenopus oocytes to study nucleolin are first, nucleolin is abundant in Xenopus oocytes (DiMario and Gall, 1990) , and second, the amplified nucleoli can be prepared for light microscopy such that their structural integrity is well preserved (Callan et al., 1987) . These amenities should allow us to study the localization of epitope-tagged wild-type and mutagenized forms of nucleolin by injecting their respective in vitro synthesized mRNAs into Xenopus oocytes. Localization of mutagenized forms of nucleolin should identify what domains are important for nucleolar associations.
The ability of nucleolin to bind both RNA and DNA in vitro has been well documented (Olson et al., 1983; Bugler et al., 1987; Sapp et al., 1989; DiMario and Gall, 1990; Barrijal et al., 1992) . We have shown that epitopetagged full-length nucleolin expressed in E. coli or in Xenopus oocytes maintains the ability to nonspecifically bind radiolabeled nucleic acids (e.g., DNA) in vitro. However, large proteolytic nucleolin fragments found in E. coli extracts that lacked short regions of their carboxy termini failed to bind radiolabeled DNA. These proteolytic truncations suggested that the GAR domain may be important for this observed in vitro nucleic acid Vol. 4, November 1993 binding activity. To specifically address this possibility, we truncated nucleolin by introducing a stop codon shortly before the GAR domain. E. coli-expressed fusion proteins truncated in this manner completely failed to bind radiolabeled probes as compared to the full-length E. coli fusion protein. This indicates that the GAR domain is important for in vitro nucleic acid binding.
The GAR-truncation expressed in Xenopus oocytes maintains some detectable binding activity. Specific posttranslational modifications such as phosphorylation within the amino terminal third of nucleolin (Ballal et al., 1975; Geahlen and Harrison, 1984; Belenguer et al., 1990; Peter et al., 1990 ) may explain why the Xenopusproduced GAR truncation maintains some binding activity versus the E. coli-produced GAR truncation. A direct comparison of the Xenopus GAR truncation and the E. coli GAR truncation may not be appropriate because of uncertainties in posttranslational modifications of the two proteins. However, we note that the in vitro binding effi,iency of the oocyte-expressed GAR truncation appears to be less than that of an endogenous full-length isoelectric variant of similar (probably less) abundance (Figure 4 , A and C). This observation suggests that the GAR domain may be required for at least efficient nucleic acid binding by intact nucleolin. Ghisolfi et al. (1992) showed that on its own, the GAR domain can bind nucleic acids in vitro with a dissociation constant of 0.5 X 106 M-1. In support of our findings, they also showed that the association of the GAR domain with nucleic acid was not as tight as that observed for intact nucleolin that had a dissociation constant of 2 X 107 M-1. The difference in dissociation constants between the GAR domain on its own versus intact nucleolin suggests that intramolecular interactions occur between the GAR domain and the rest of the protein to enhance nucleic acid binding.
Such intramolecular interactions have been previously suggested for proper nucleolin function. For example, Sapp et al. (1989) described a sixfold higher renaturation rate for heat-denatured DNA restriction fragments in the presence of intact nucleolin as compared to the renaturation rate observed for just the 48-kDa carboxy two-thirds of nucleolin. Their results suggested that an interaction between the amino terminal third and the carboxy terminal two-thirds facilitates single-strand DNA renaturation. Second, Olson et al. (1990) showed a substantial increase in chymotrypsin sensitivity within the amino terminal third when intact nucleolin was incubated in the presence of poly [G] versus in the absence of poly [G] . Because the four RNAbinding domains were chiefly responsible for binding poly [G] , these latter results indicated that a conformational change takes place within the amino terminal third of nucleolin when the protein's carboxy two-thirds binds nucleic acid.
We have used radiolabeled single-stranded DNA in our Southwestern assays mostly to monitor the presence and nucleic acid binding capabilities of nucleolin under defined in vitro conditions. Although specific in vitro nucleolin-DNA interactions have been noted (Barrijal et al., 1992) , we stress that our Southwestern assays should not be interpreted to reflect in vivo function. The demonstration that the GAR domain is important for nucleic acid interaction in our filter binding assays, however, suggests that it may also play an important role in the proper in vivo association with nucleic acids in the nucleoli. Therefore, in an attempt to study nucleolin's in vivo associations, we expressed epitopetagged full-length and GAR-truncated nucleolin in Xenopus oocytes.
Immunofluorescence results showed that full-length myc-tagged nucleolin properly translocates to the nuclei and then associates with nucleoli despite the tags on the amino terminal end and the presence of endogenous nucleolin within the nucleoli. This proper localization suggests that the full-length fusion protein has the potential to function normally in vivo. Previous nucleolar localization studies by Peculis and Gall (1992) showed that Xenopus nucleolar protein, N038, properly localizes to oocyte nucleoli when a single myc epitope was used as the tag.
The full length myc-tagged nucleolin also localized to extranucleolar RNP particles. This simply may be a result of an overexpression of fusion protein within the oocytes. However, our rabbit anti-nucleolin serum, R2D2, also labeled extranucleolar RNP particles within the nuclei of noninjected oocytes ( Figure 6C ). This extranucleolar nucleolin may be involved either in shuttling (Borer et al., 1989) or perhaps in the processing of RNAs other than ribosomal RNA. The myc-tagged GAR The preparation in A was reprobed with rabbit anti-nucleolin serum, R2D2, and rhodamine-coupled mouse anti-rabbit IgG to localize endogenous and tagged nucleolin. Similar staining patterns in B and C indicated that the myc-tagged fusion properly localized to the nucleoli. As a control for cross-reactivity, a similar preparation (A, top right inset) was probed mAb 9E10 and fluorescein-coupled goat anti-mouse (B, top right inset) and then with only the rhodamine-coupled secondary antibody, not R2D2 (C, top right inset). No 4, November 1993 truncation also localized to the extranucleolar RNP material ( Figure 7H ), perhaps by interactions with its four intact RNA-binding domains. Further investigations into the extranucleolar localization of nucleolin within amphibian oocyte nuclei are underway (Rankin and DiMario, unpublished data).
Our myc-tagged nucleolin GAR truncation failed to efficiently localize to the multiple nucleoli despite its translocation into the nuclei and its accumulation within the extranucleolar RNP material ( Figure 7H) . Failure of the GAR truncation to specifically associate with nucleoli may be because of an absence of direct interactions that normally occur between the GAR domain and nucleolar macromolecules such as rRNA, or perhaps other nucleolar proteins. Alternatively, various other nucleolin domains such as the four RNA-binding domains or the alternating basic and acidic regions may fail to properly interact with nucleolar macromolecules because of improper tertiary configurations that normally occur when the GAR domain is present.
Other proteins that contain GAR-like domains include fibrillarin (referred to as NOP1 in yeast) that associates with nucleolar U3 snRNA and plays a positive role in pre-rRNA processing (Kass et al., 1990) , the yeast nucleolar protein GAR 1 that is essential for pre-rRNA processing (Girard et al., 1992) , the yeast nucleolar protein SSB-1 (Jong et al., 1987) that associates with small nuclear RNAs snRlO and snR1l (Clark et al., 1990) , NSR1 that is the yeast analogue of vertebrate nucleolin (Kondo et al., 1992a,b) , and the vertebrate hnRNP proteins Al and U . In addition, the protein product of the fragile X gene, FMR1, has recently been shown to contain a GAR domain (referred to as the RGG box by Siomi et al., 1993) . The FMR1 protein binds RNA in vitro, and deletion of its GAR domain removes the capacity of this protein to bind RNA in vitro (Siomi et al., 1993) . We have shown that the GAR domain of nucleolin is also necessary for in vitro nucleic acid binding and specific localization of nucleolin within nucleoli. We are currently testing whether nucleolin's GAR domain can confer RNA-binding and nucleolar localization characteristics on non-RNA-binding, nonnucleolar proteins.
